Hvidovre Høreapparatsklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.7% 17.6% 16.0% 17.9% 16.4%  
Credit score (0-100)  9 9 10 8 10  
Credit rating  B B BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -9.8 -0.8 -4.1 -4.1 -4.8  
EBITDA  -9.8 -0.8 -4.1 -4.1 -4.8  
EBIT  -9.8 -0.8 -4.1 -4.1 -4.8  
Pre-tax profit (PTP)  -9.9 -1.0 -4.4 -4.4 -4.7  
Net earnings  -7.7 -0.8 -3.5 -3.5 -3.6  
Pre-tax profit without non-rec. items  -9.9 -1.0 -4.4 -4.4 -4.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  32.3 31.5 28.0 24.6 20.9  
Interest-bearing liabilities  0.0 4.1 8.3 12.4 17.1  
Balance sheet total (assets)  35.4 38.7 39.4 40.1 41.2  

Net Debt  -33.2 -32.2 -27.8 -23.4 -18.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -9.8 -0.8 -4.1 -4.1 -4.8  
Gross profit growth  0.0% 92.1% -432.3% 0.0% -15.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  35 39 39 40 41  
Balance sheet change%  0.0% 9.4% 1.7% 1.7% 2.8%  
Added value  -9.8 -0.8 -4.1 -4.1 -4.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -27.7% -2.1% -10.6% -10.4% -11.6%  
ROI %  -30.3% -2.3% -11.5% -11.3% -12.5%  
ROE %  -23.9% -2.5% -11.7% -13.1% -16.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  91.2% 81.3% 71.1% 61.3% 50.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  339.4% 4,158.5% 673.6% 566.3% 393.0%  
Gearing %  0.0% 13.1% 29.5% 50.4% 81.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 11.8% 5.1% 2.9% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  11.3 5.3 3.5 2.6 2.0  
Current Ratio  11.3 5.3 3.5 2.6 2.0  
Cash and cash equivalent  33.2 36.4 36.0 35.7 35.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  32.3 31.5 28.0 24.6 20.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0